Title: VALOR, an adaptive design, pivotal phase III trial of vosaroxin or placebo in combination with cytarabine in first relapsed or refractory acute myeloid leukemia
Authors: Ravandi, Farhad
Ritchie, Ellen K
Sayar, Hamid
Strickland, Stephen Anthony
Craig, Michael
Selleslag, Dominik L. D
Maertens, Johan
Havelange, Violaine
Lancet, Jeffrey E
Ketchum, Steven B
Acton, Gary
Mehta, Cyrus R
Silva, Eric
Craig, Adam
Fox, Judith Ann
Stuart, Robert K
Erba, Harry Paul
Vey, Norbert
Schiller, Gary J
Feldman, Eric Jay
Issue Date: 2012
Publisher: Grune & Stratton
Host Document: Journal of Clinical Oncology vol:30 issue:15
Conference: 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) location:Chicago: IL date:JUN 01-06, 2012
ISSN: 0732-183X
Publication status: published
KU Leuven publication type: IMa
Appears in Collections:Department of Microbiology & Immunology - miscellaneous
Laboratory of Experimental Hematology (+)

Files in This Item:

There are no files associated with this item.


All items in Lirias are protected by copyright, with all rights reserved.